BostonGene CEO to Keynote MWC Barcelona 2026 on AI Governance
Event summary
- BostonGene CEO Andrew Feinberg will deliver a main stage keynote at MWC Barcelona 2026 on March 3, 2026.
- Feinberg will discuss AI governance, drawing from his dual leadership roles in oncology and telecom.
- BostonGene's AI platform integrates multimodal biological data for precision oncology and drug development.
- The keynote will explore AI's impact on high-impact industries, including telecommunications and life sciences.
The big picture
BostonGene's invitation to keynote MWC Barcelona underscores the growing intersection of AI governance across industries. As AI reshapes sectors from precision oncology to telecommunications, the company's approach to scaling intelligence with rigorous governance could set new standards for global tech leadership. The keynote highlights the strategic importance of cross-industry collaboration in deploying AI responsibly.
What we're watching
- Governance Dynamics
- How BostonGene's framework for AI governance in oncology will influence telecom and other sectors.
- Cross-Industry Adoption
- The pace at which lessons from oncology AI deployment will be applied to global telecommunications infrastructure.
- Strategic Positioning
- Whether BostonGene can leverage this platform to strengthen partnerships with biopharma and leading cancer centers.
Related topics